Protagonist Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
70%
€80.50
Target price
31.12.25
€40.00
Performance (%)
-
End price
31.08.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -1.829% | -1.829% | 269.266% |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% |
According to BiotechBee what are the pros and cons of Protagonist Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year